Revealix
Revealix is a developer of an analytics medical software designed to detect skin diseases. The company's software monitors and analyzes for diabetic limb complications in the palm of the hand by affordable monitoring tools via a web-based analytics platform, enabling healthcare providers to detect the earliest phases of skin and wound complications.
Revealix
Revealix is a developer of an analytics medical software designed to detect skin diseases. The company's software monitors and analyzes for diabetic limb complications in the palm of the hand by affordable monitoring tools via a web-based analytics platform, enabling healthcare providers to detect the earliest phases of skin and wound complications.
TL;DR
Headquarters: Austin, Texas, United States
Product: Clinical decision-support platform for diabetic foot/skin health (mobile-first, 3-minute workflow, optional thermal imaging)
Founders / CEO: Adrianna Cantu (Co‑Founder & CEO), Gary Johnson, Stuart Rench
Employees: Approximately 3
Funding: Two events including a Seed (Sep 9, 2019) and a Non-equity Assistance event (Sep 27, 2024)
Company Overview
Problem Domain
Diabetic foot and skin wound prevention; clinical screening and risk stratification for limb complications.
Industry
Healthtech / Medical Software